AnthracyclinesNaphthacenesAntibiotics, AntineoplasticDaunorubicinAclarubicinCarubicinNogalamycinDoxorubicinRazoxaneIdarubicinMenogarilLeukemia P388EpirubicinBridged CompoundsStreptomycesBreast NeoplasmsExtravasation of Diagnostic and Therapeutic MaterialsLeukemia L1210Antineoplastic AgentsIntercalating AgentsCardiotoxinsMolecular StructureHeart DiseasesAntineoplastic Combined Chemotherapy ProtocolsTaxoidsStructure-Activity RelationshipMagnetic Resonance SpectroscopyCardiomyopathiesGlycosidesDrug ResistanceDrug Resistance, NeoplasmP-GlycoproteinChemistryDose-Response Relationship, DrugChemical PhenomenaDNA Topoisomerases, Type IIHeartMitoxantroneVerapamilPhysicochemical PhenomenaDrug Screening Assays, AntitumorDrug Resistance, MultipleEpothilonesChemistry, PhysicalCytarabineAnthraquinonesTreatment OutcomeChemotherapy, AdjuvantFluorouracilHydrazonesNeoplasm MetastasisDisease-Free SurvivalCyclophosphamideVinblastineNeoplasmsPaclitaxelCinchona AlkaloidsKineticsFermentationStereoisomerismTumor Cells, CulturedDrug Administration ScheduleChromatography, Thin LayerChromatography, High Pressure LiquidReceptor, erbB-2Neoadjuvant TherapyDeoxycytidineCell SurvivalDrug Evaluation, PreclinicalMolecular ConformationLeukemia, Promyelocytic, AcuteSpectrophotometry, InfraredSurvival AnalysisLeukemia, Myeloid, AcuteKetonesCardiotonic AgentsLeukemia, ExperimentalTime FactorsFuransNocardiaceaeMicromonosporaDNAVentricular Function, LeftRemission InductionMolecular Sequence DataTopoisomerase II InhibitorsAminoacridinesHeart Function TestsHL-60 CellsVincristineMyocardiumCell LineBiotransformationAnti-Bacterial AgentsCell Line, TumorNocardiaOxidation-ReductionSurvivorsEmodinMitomycin